Immunobiogram is the only platform in the world to help assess the sensitivity of immunosuppressant drug and its dosage prior to transplant.
Our Solutions
Duraent prioritizes customer satisfaction by listening to their needs, tailoring products and services accordingly, and exceeding expectations through a customer-centric approach
Immunobiogram
Revolutionizing kidney transplant care with a blood-based test, personalising immunosuppressive therapy for each patient, ensuring precision and better outcomes.
OmniGraf
The first non-invasive blood test that empowers clinicians to confidently rule out subclinical acute rejection and ensure optimal immune system management in liver transplant patients.
Trugraf Kidney
First non-invasive blood test to rule out subclinical acute rejection (subAR) during Stable Renal Function.
TRAC
Firstnon-invasive blood test to rule out clinical acute rejection in Renal Dysfunction.
TRAC ID
Non-invasive means to monitor the risk of graft rejection and infection in kidney transplant recipients.
